1
|
Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action. Pediatr Blood Cancer 2019; 66:e27657. [PMID: 30724025 DOI: 10.1002/pbc.27657] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2018] [Revised: 01/22/2019] [Accepted: 01/27/2019] [Indexed: 01/01/2023]
Abstract
BACKGROUND Sickle cell disease (SCD) is a chronic multisystem disorder requiring comprehensive care that includes newborn screening (NBS) as the first step of care. Italy still lacks a national SCD NBS program and policy on blood disorders. Pilot single-center screening programs and a regional targeted screening have been implemented so far, but more evidence is needed in order to impact health policies. POPULATION AND METHODS NBS was offered to parents of newborns in gynecology clinics in Padova and Monza, tertiary care university hospitals in northern Italy. High-performance liquid chromatography (HPLC) was performed as the first test on samples collected on Guthrie cards. Molecular analysis of the beta-globin gene was performed on positive samples. RESULTS A total of 5466 newborns were enrolled; for 5439, informed consents were obtained. A similar family origin was seen in the two centers (65% Italians, 9% mixed couples, 26% immigrants). Compared with SCD NBS programs in the United States and Europe, our results show a similar incidence of SCD patients and carriers. All SCD patients had a Sub-Saharan family background; HbS carriers were 15% Caucasians (Italian, Albanians) and 10% from other areas (North Africa-India-South America); carriers of other hemoglobin variants were mainly (47%) from other areas. CONCLUSIONS Our results demonstrate the feasibility of a multicentric NBS program for SCD, give information on HbS epidemiology in two Northern Italian Areas, and support previous European recommendation for a universal NBS program for SCD in Italy: a high incidence of patients and carriers has been detected, with a high percentage of Caucasian carriers, impossible to identify in a targeted NBS.
Collapse
Affiliation(s)
- Raffaella Colombatti
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Maddalena Martella
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Laura Cattaneo
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | - Giampietro Viola
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Anita Cappellari
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Chiara Bergamo
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Silvia Azzena
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Sara Schiavon
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Eugenio Baraldi
- Neonatal Unit, Department of Child and Maternal Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Beatrice Dalla Barba
- Neonatal Unit, Department of Child and Maternal Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Ursula Trafojer
- Neonatal Unit, Department of Child and Maternal Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Paola Corti
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | - Marzia Uggeri
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | | | - Chiara Zorloni
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | - Michela Bracchi
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | - Andrea Biondi
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | - Giuseppe Basso
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| | - Nicoletta Masera
- Department of Pediatrics-Università di Mitlano Bicocca, Fondazione MBBM, Monza, Italy
| | - Laura Sainati
- Clinic of Pediatric Hematology Oncology, Department of Woman's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
| |
Collapse
|
2
|
Bunone G, Uggeri M, Mondellini P, Pierotti MA, Bongarzone I. RET receptor expression in thyroid follicular epithelial cell-derived tumors. Cancer Res 2000; 60:2845-9. [PMID: 10850426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
The RET proto-oncogene encodes a receptor tyrosine kinase for transforming growth factor-beta-related neurotrophic factors, which include GDNF and neurturin. The expression of RET proto-oncogene was detected in several tissues, such as spleen, thymus, lymph nodes, salivary gland, and spinal cord, and in several neural crest-derived cell lines. RET expression in the thyroid gland was reported to be restricted to neural crest-derived C cells. The presence of RET mRNA or protein has not yet been reported in thyroid follicular cells. We previously demonstrated the expression of oncogenic rearranged versions of RET in papillary thyroid carcinomas: tumors derived from thyroid follicular cells. To assess the expression of the normal RET proto-oncogene in follicular cells, we analyzed its expression in a panel of neoplasias originating from thyroid follicular epithelial cells: papillary carcinomas and both follicular adenomas and carcinomas. We also demonstrated the presence of RET normal transcripts in two follicular thyroid carcinoma lymph node metastases. Moreover, we found the presence of the RET/ELE1 transcript, the reciprocal complementary form of the oncogenic fusion transcript ELE1/RET, in a papillary thyroid carcinoma specimen expressing the RET/PTC3 oncogene, thus demonstrating that the RET promoter is active in those cells after rearrangement. Finally, we show that in a papillary carcinoma-derived cell line expressing the proto-RET receptor and the related GFRalpha2 co-receptor, GDNF treatment induced RET tyrosine phosphorylation and subsequent signal transduction pathway, indicating that RET could be active in thyroid follicular cells.
Collapse
Affiliation(s)
- G Bunone
- Division of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy
| | | | | | | | | |
Collapse
|
3
|
Bongarzone I, Vigano E, Alberti L, Mondellini P, Uggeri M, Pasini B, Borrello MG, Pierotti MA. The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. Oncogene 1999; 18:4833-8. [PMID: 10490816 DOI: 10.1038/sj.onc.1202848] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Mutations of the RET gene, encoding a receptor tyrosine kinase, have been associated with the inherited cancer syndromes MEN 2A and MEN 2B. They have also further been associated with both familial and sporadic medullary thyroid carcinomas. Missense mutations affecting cysteine residues within the extracellular domain of the receptor causes constitutive tyrosine kinase activation through the formation of disulfide-bonded homodimers. We have recently reported that a somatic 6 bp in-frame deletion, originally coding for Glu632-Leu633, potently activates the RET gene. This activation is increased with respect to the frequent MEN 2A-associated missense mutation Cys634Arg. This finding specifically correlated to the clinic behavior of the corresponding tumor, which was characterized by an unusually aggressive progression with both multiple and recurrent metastases. By examining the possibility that this deletion acts in a manner similar to cysteine substitution, we have analysed the molecular mechanism by which this oncogenic activation occurs. Phosphorylated dimers of the deleted Ret receptor were detected in immunoprecipitates separated under non-reducing conditions. Like other Cys point mutations, this 6 bp deletion affecting two amino acid residues between two adjacent Cys, is capable of activating the transforming ability of Ret by promoting receptor dimerization. These results suggest that alteration to cysteine residue position or pairing is capable of inducing ligand independent dimerization. Furthermore, we present data demonstrating that the processing and sorting of the Ret membrane receptor to the cell surface is affected by mutation type.
Collapse
Affiliation(s)
- I Bongarzone
- Division of Experimental Oncology A, Instituto Nazionale Tumori, 20133 Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Selletti L, Taveggia G, Grioni G, Uggeri M, Loda M, Pastorelli GM. [Principles of a rehabilitation treatment for returning to work after a stabilization intervention with the Colorado method]. G Ital Med Lav Ergon 1997; 19:76-9. [PMID: 9463048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The Authors report their experience on the method of Colorado Spinal System for reduction in spondylolisthesis; they describe a postoperative rehabilitative programme for a complete and quick functional recovery. They eventually report the clinical results achieved in 15 patients.
Collapse
Affiliation(s)
- L Selletti
- Fondazione S. Maugeri, Clinica del Lavoro e della Riabilitazione, IRCCS Istituto di Riabilitazione di Castel Goffredo
| | | | | | | | | | | |
Collapse
|
5
|
Uggeri M. [Piezo-ceramic lithotripsy applied to calculi of the bile ducts. Experiences with 45 patients]. Arch Ital Urol Nefrol Androl 1989; 61:423-5. [PMID: 2532408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Forty five patients with gallbladder stones has been treated by extracorporeal lithotripsy with piezoceramic lithotripter. The efficacy, the safety and the side effects of the treatment had been evaluated. In 40 patients the stone was completely broken, 35 patients needed more than a single treatment (1 to 5). All the treatments were carried out in local anesthesia without any analgesia drug. No one patients complained for any pain. The side effects recorded were 3 cases of microscopic hematuria, 2 cases slight increase of serum parameters of hepatic functionality, in 7 cases skin petecchiae. No mayor effects were noted.
Collapse
|